Topic Hub
4 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 4 of 4 clinical reviews.
Does Fosamax raise or lower 25-OH vitamin D? A clinical breakdown of alendronate's effect on vitamin D status, monitoring timelines, and supplementation guidance backed by RCT and guideline evidence.
Read clinical reviewAlendronate (Fosamax) lowers alkaline phosphatase by 25-30% within 3-6 months by suppressing osteoclast-mediated bone resorption. Learn the mechanism, expected timeline, monitoring guidance, and what ALP changes mean for your osteoporosis treatment.
Read clinical reviewAlendronate increases DEXA bone mineral density by 5 to 8% at the spine and 3 to 4% at the hip over 3 to 4 years. Learn the mechanism, timeline, monitoring schedule, and trial data behind Fosamax's effect on bone density.
Read clinical reviewAlendronate can shift several CMP markers, including serum calcium, alkaline phosphatase, and renal function. Learn the direction, magnitude, timing, and monitoring protocols backed by clinical trial data.
Read clinical review